C O M M U N I C A T I O N S
Figure 1. Mitochondrial-targeted light-mediated release strategy. Photolysis
releases the quencher (and any associated biochemically active agent “X”)
from the mitochondrial surface into the cytoplasm.
fluorescence resonance energy transfer (FRET) and collisional
quenching] and thus deliver a larger fluorescent response. Second,
nitrobenzyl derivatives are modest quenchers of fluorescence as
well.5 Cassettes in which photolysis detaches the nitrobenzyl-based
photolinkers from the fluorophore-appended segment (e.g., 4-5-8)
produce larger fluorescence changes than the corresponding cas-
settes in which the nitrobenzyl linker remains associated with the
fluorophore (e.g., 8-5-4). These large fluorescence changes can
be easily observed using a handheld UV-vis lamp (see the movie
in the Supporting Information), which both photolyzes the linker
and excites the fluorophore.
Figure 2. HeLa cells exposed to CPMLS-4-5-7 and mitotracker FarRed:
row A (unphotolyzed), row B (photolyzed); column 1 (Cy 3 window, green,
TAMRA-labeled peptide), column 2 (Cy 5.5 window, red, mitotracker
FarRed), column 3 (merged columns 1 and 2, orange signifies regions of
overlap, Pearson coefficient 0.88 ( 0.03); green circle (laser focus).
S-12 and S-13) with little remaining in the supernatant, as assessed
by visual inspection as well as absorbance and fluorescence spectros-
copy. Photolysis produces a sharp increase in supernatant absorbance,
consistent with the release of the colored fluorescence quencher 8 from
the mitochondria. Mitochondrial fluorescence quantitation was assessed
via flow cytometry,9 which revealed a light-mediated 13.4-fold
fluorescence enhancement (Figure S-13).
Unfortunately, the Trp-induced dim fluorescence of photolyzed
MLS-PEG-4-5-8 precluded single-cell imaging experiments.
Consequently, we synthesized alternative constructs that utilized the
cell-permeable MLS (CPMLS)10 Ac-Fx-r-Fx-K-Fx-r-Fx-K, where Fx
) cyclohexyl-Ala and r ) D-Arg); CPMLS-4-5-7 furnished the
largest light-induced fluorescence change (51-fold; Figure S-8).
Exposure of HeLa cells to CPMLS-4-5-7 and subsequent photolysis
produced an (11.8 ( 0.7)-fold fluorescence increase and subcellular
mitochondrial localization as assessed by overlap with mitotracker
FarRed (Figure 2). In contrast, photolyzed 4-5-8 gave a diffuse
pattern similar to TAMRA itself (Figure S-16).
We have identified a series of photolabile fluorescently quenched
cassettes that display large fluorescence enhancements upon pho-
tolysis. Cassette-containing MLS peptides are mitochondrially
absorbed and photolyzed in the expected fashion. These reagents
are under evaluation as the basis for a new strategy for spatial
manipulation of intracellular biochemical activity.
The construction of “caged” compounds commonly relies upon
transformation of a biologically active species into an inert
derivative via covalent modification of an essential functional group
with a light-sensitive moiety.1 However, direct modification of a
single key site for complete biological caging purposes is not always
feasible. It occurred to us that an alternative approach for
manipulating activity would be light-driven spatial control of the
cellular distribution of the biological entity. For example, mito-
chondrial localization sequences (MLSs), as well as related species,
could be used to deliver activators (or inhibitors) to mitochondria,
thereby triggering (or inhibiting) an organelle-specific biochemical
cascade.6 If the bioactive species were linked to the MLS via a
photocleavable moiety, then photolysis could potentially be used
to switch off mitochondrial-specific activity via release of the active
reagent from the MLS, leading to its subsequent dilution in the
cytoplasm (Figure 1). We used cassettes from Table 1 to examine
this “organelle targeted/light-mediated release strategy”.
Acknowledgment. We thank the NIH (CA79954) for financial
support.
Supporting Information Available: Details of the quenched
fluorophore cassette and MLS peptide syntheses and the photolysis,
mitochondrial, and cellular studies; movie (QT) showing fluorescence
changes. This material is available free of charge via the Internet at
References
The peptide MLALLGWWWFFSRKK-PEG-4-5-8-amide
(“MLS-PEG-4-5-8”), where the italicized component is based
on an MLS that targets the mitochondrial outer membrane7 and
PEG ) -NHCH2(CH2CH2O)3(CH2)3NHCO-CH2OCH2CO-, was
prepared via solid-phase peptide synthesis. Photolysis of
MLS-PEG-4-5-8 splits the quencher (8) from the TAMRA (4)-
appended peptide, which furnishes an 11-fold fluorescence enhance-
ment (Figure S-7). The latter is dramatically reduced from the
fluorescence yield observed for the 4-5-8 cassette itself, which
we ascribe to the presence of the MLS Trp (a known fluorescence
quencher8) triplet. The mauve-colored MLS-PEG-4-5-8 is
rapidly taken up by isolated bovine heart mitochondria (Figures
(1) (a) Lee, H. M.; Larson, D. R.; Lawrence, D. S. ACS Chem. Biol. 2009, 4,
409. (b) Mayer, G.; Heckel, A. Angew. Chem., Int. Ed. 2006, 45, 4900.
(2) Pellois, J. P.; Hahn, M. E.; Muir, T. W. J. Am. Chem. Soc. 2004, 126,
7170.
(3) Majjigapu, J. R.; Kurchan, A. N.; Kottani, R.; Gustafson, T. P.; Kutateladze,
A. G. J. Am. Chem. Soc. 2005, 127, 12458.
(4) Sharma, V.; Lawrence, D. S. Angew. Chem., Int. Ed. 2009, 48, 7290.
(5) Carmel, A.; Keller, E.; Yaron, A. Eur. J. Biochem. 1977, 73, 617.
(6) Yousif, L. M.; Stewart, K. M.; Kelley, S. O. ChemBioChem 2009, 10, 1939.
(7) Huang, L. J.; Wang, L.; Ma, Y.; Durick, K.; Perkins, G.; Deerinck, T. J.;
Ellisman, M. H.; Taylor, S. S. J. Cell Biol. 1999, 145, 951.
(8) Doose, S.; Neuweiler, H.; Sauer, M. ChemPhysChem 2005, 6, 2277.
(9) Fuller, K. M.; Arriaga, E. A. Curr. Opin. Biotechnol. 2003, 14, 35.
(10) Horton, K. L.; Stewart, K. M.; Fonseca, S. B.; Guo, Q.; Kelley, S. O. Chem.
Biol. 2008, 15, 315.
JA907427P
9
J. AM. CHEM. SOC. VOL. 132, NO. 5, 2010 1447